biomedicina slovenica


re="Farm Vestn" : 738-837

  1. Bernkop-Schnuerch A; Scerbe-Saiko A
    Intestinal peptide and protein delivery: synthesis and evaluation of a chitosan-inhibitor conjugate
    1997
  2. Bernkop-Schnuerch A
    Intestinal peptide and protein delivery: co-administration of protease inhibitors
    1997
  3. Carli Fabio
    Mechano-chemical activation for drug delivery
    1997
  4. Mrhar Aleš
    Proceedings of the symposium 2nd Central European symposium on pharmaceutical technology; 1997 Sep 25-26; Portorož
    1997
  5. Pirš Janez; Eržen Vital; Marin Bojan; Blinc Robert; Gomišček Gregor; Fercher Adolf Friedrich; Moser Ewald
    Miniature MR imager with permanent magnet
    [Miniaturni MR tomograf s permanentnim magnetom]
    1990
  6. Gomišček Gregor; Holzmueller Peter; Moser Ewald
    Quantitative MR-imaging of rat liver damage
    [Kvantitativno slikanje okvare podganjih jeter z magnetno resonanco]
    1990
  7. Brumen M; Svetina S; Žekš B
    Elastic properties of the red blood cell membrane in a model of three coupled layers
    [Elastične lastnosti membrane eritrocita v modelu treh sklopljenih plasti]
    1987
  8. Valenčič D
    50 let šole farmacevtske tehnike v Ljubljani
    1996
  9. Tršinar M; Zamljen S
    Opustite kajenje
    1996
  10. Lenart K
    Zasvojenost z nikotinom in nikotinsko nadomestno zdravljenje
    [Nocotine addiction and nicotine replacement therapy]
    1996
  11. Zupančič-Brouwer N; Boh B
    Metode utrjevanja želatinskih mikrokapsul
    [Methods of hardening gelatin microcapsules]
    1996
  12. Lipnik-Štangelj M
    Nesteroidne protivnetne spojine: mehanizem delovanja in farmakološki učinki
    [Non-steroidal anti-inflammatory drugs: mechanism of action and pharmacological effects]
    1996
  13. Bole-Vunduk B
    Vpliv felodipina, primerjan z verapamilom in diltiazemom, na arterijski krvni tlak in frekvenco srčnega utripa pri anesteziranih podganah in podganah z uničenim osrednjim živčnim sistemom
    [Influence of felodipine in comparison with verapamil and diltiazem on the arterial pressure and heart rate in normotensive and pithed rats]
    1996
  14. Ahlin P; Kristl J; Grošelj D
    Izdelki za ohranjanje zdravlja zob in ustne votline
    [Dental and oral health products]
    1996
  15. Gobec S; Urleb U
    Aminofosfonske kisline in fosfapeptidi
    [Aminophosphonic acids and phosphapeptides]
    1996
  16. Mlinarič-Raščan I
    Vloga protein tirozin fosfataze PTP1C v razvoju in delovanju limfocitov T
    [The role of the protein tyrosine phosphatase PTP1C in the development and function of T lymphocytes]
    1996
  17. Rataj S
    Manji Hropot, ing farm. V slovo
    1996
  18. Anonymous ;
    V spomin mr. ph. Stjepanu Pavišiću - Štefu
    1996
  19. Anonymous ;
    Alenki v slovo
    1996
  20. Špringer J
    Rex pharmaceuticalis: kralj našega preživetja ali deset odličnih lekarniških povedi
    1996
  21. Spieser JM
    Regulatory requirements and standardisation of biotechnological medicinal products in Europe and progress towards international harmonisation
    1996
  22. Vrečer M
    Uvod v farmakoekonomiko
    [Introduction to pharmaco-economics]
    1996
  23. Grabnar I; Belič A; Mrhar A; Karba R
    Vloga modeliranja in simulacije pri načrtovanju zdravil
    [The role of modeling and simulation in drug design]
    1996
  24. Lipnik-Štangelj M; Ferjan I; Erjavec F
    Ugotavljanje učinkovitosti nesteroidnih protivnetnih spojin; vpliv na sproščanje histamina iz mastocitov
    [Activity investigations of non-steroidal anti-inflammatory drugs; the effect on histamine secretion from mast cells]
    1996
  25. Bole-Vunduk B
    Predklinične raziskave o protivnetnem in analgetičnem delovanju nabumetona
    [Preclinical studies of anti-inflammatory and analgesic activity of nabumetone]
    1996
  26. Maček-Lebar Alenka; Damjanić Frano B; Antolič Vane; Iglič Aleš; Srakar France; Brajnik Dušan
    Nepravilnosti v cementnem plašču: analiza z metodo končnih elementov
    [Cement filling of efect: a finite element analysis]
    1996
  27. Ušaj A; Strojnik V; Jarh O; Demšar F
    Učinek pet tedenske vadbe na mišični pH pri naporu je različen, če uporabimo izometrična ali dinamična krčenja
    [Muscle pH at exercise was differently affected by five weeks of training using isometric or dynamic contractions]
    1996
  28. Srakar F; Iglič A; Maček-Lebar A; Antolič V
    The relative strength of the hip abductors after valgus osteotomy in congenital coxa vara
    [Relativna moč kolčnih abduktorjev po valgizacijski osteotomiji pri zdravljenju prirojene coxe vare]
    1996
  29. Makovec T; Breskvar K; Hudnik-Plevnik T
    Rekonstitucija aktivnosti steroidne hidroksilaze z encimskimi komponentami iz glive Rhizopus nigricans in goveje nadledvične žleze
    [Reconstitution of steroid hydroxylase activity with enzyme components from rhizopus nigricans and bovine adrenal gland]
    1996
  30. Rupreht R; Plemenitaš A
    Use of antibodies in the system of semi-intact cells
    [Uporaba protiteles v sistemu semi-intaktnih celic]
    1996
  31. Plemenitaš A
    Semi-intaktne celice: eksperimentalni model za študij metaboličnih procesov
    [Semi-intact cells, an experimentalmodel for the studies of metabolic processes]
    1996
  32. Ihan A
    Analiza imunskih celic s pretočnim citometrom
    [Flow cytometry for immune cell analysis]
    1996
  33. Vrhovnik K; Krbavčič A
    Izbrani analizni postopki za vrednotenje lipidov
    [Selected analytical methods for lipid determination]
    1996
  34. Gladovič Nataša; Ritlop-Božič Rozina
    Bršljanov list
    [Hederae helicis folium]
    1996
  35. Koren A
    Vpliv CO2-izzvane acidoze na kontrakcijske značilnosti izoliranega soleusa laboratorijske podgane
    [Effect of carbon dioxide-induced acidosis on contraction characterics of isolated soleus rat muscle]
    1996
  36. Virant-Doberlet M; Horseman G; Hartmann R; Loher W; Huber F
    A new approach for measuring juvenile hormone production
    [Nov pristop k merjenju sinteze juvenilnega hormona]
    1996
  37. Budihna MV; Grebenc H
    Racemic nicardipine and its (-) enantiomer dose-dependently inhibit intestinal absorption of digoxin in guinea-pig in vivo
    [Racemni nikardipin in njegov (-) enantiomer od doze odvisno zavirata črevesno absorpcijo digoksina pri morskem prašičku in vivo]
    1996
  38. Meh D; Denišlič M; Popović M
    Morphological confirmation of clinically and psychophysiologically established small nerve fibre dysfunction
    1996
  39. Brumen M; Heinrich R
    Theoretical investigation of lipid translocation fluxes in the membrane bilayer
    1996
  40. Kastelic-Suhadolc T; Lenasi H
    Androgen binding proteins in the cytosol and in the plasma membrane of Cochliobolus lunatus
    1996
  41. Lenasi H; Plemenitaš A; Hudnik-Plevnik T
    Progesterone binding sites in the plasma membrane of filamentous fungi Rhizopus nigricans and Cochliobolus lunatus
    1996
  42. Foeldešiova V; Kolar J; Špringer V
    Analysis of the prescription of antibiotics at a hospital department of surgery
    1996
  43. Gabrijelčič V; Šentjurc M
    Liposomi v dermofarmacevtskih in kozmetičnih pripravkih
    [Liposomes in dermatics and cosmetics]
    1991
  44. Šegedin D; Jermol A; Krsmanovič M; Žitnik D
    Farmacevtska skrb
    [Pharmaceutical care]
    1996
  45. Vučko S
    Anatomsko-terapevtično-kemijska (ATC) klasifikacija zdravil
    [The anatomical therapeutic chemical (ATC) classification system]
    1996
  46. Kozin-Simčič S; Kozjek F
    Stabilnost kozmetičnih emulzij
    [Cosmetic emulsions stability]
    1996
  47. Srčič S; Planinšek O; Sollner M; Pečar S
    Termične lastnosti N-(7-oksoacil)-L-alanil-D-izoglutaminov
    [Thermal behaviour of N-(7-oxoacyl)-L-alanyl-D-isoglutamines]
    1996
  48. Planinšek O; Srčič S; Kerč J
    Določanje površinske energije trdnih snovi
    [Determination of surface energy of solids]
    1996
  49. Kristl J; Kočevar-Nared J; Šmid-Korbar J
    Vpliv bioanorganskih in organskih spojin na viskoelastične lastnosti mucina
    [Influence of bioanorganic and organic compounds on viscoelastic properties of mucin]
    1996
  50. Kuzman T; Kikelj D
    Stereoizomerija karbapenemov in njen vpliv na biološko učinkovitost
    [Stereoisomerism of carbapenems and its influence on biological activity]
    1996
  51. Beravs K; Sollner M; Pečar S
    Problemi priprave spinsko označenih aminokislin
    [The problems of the synthesis of spin-labeled aminoacids]
    1996
  52. Dolinar J
    Glavni urednik Farmacevtskega vestnika - šestdesetletnik
    1996
  53. Pečar Slavko
    Prof. dr. Aleš Krbavčič - šestdesetletnik
    1996
  54. Zupančič-Božič D; Vrečer F; Kozjek F
    Optimization of dissolution: using artificial neural network
    1996
  55. Cvelbar M
    Nadzor kakovosti in varnost biotehnoloških farmacevtskih izdelkov
    [Quality control and relevant safety of biotechnological medicinal products]
    1996
  56. Kveder R; Bren AF; Varl J
    Izkušnje pri kliničnem testiranju in uporabi humanega rekombinantnega eritropoetina (r-Hu-EPO)
    [Experiences with clinical testing and usage of recombinant human erythropoietin (r-Hu-EPO)]
    1996
  57. Šabovič M
    Vloga rekombinantnih zdravil v zdravljenju kardiovaskularnih bolezni
    [The role of recombinant drugs in the treatment of cardiovascular diseases]
    1996
  58. Štalc A
    Pregled v zdravljenje uvedenih rekombinantnih zdravil
    [A review of recombinant drugs introduced into the therapy]
    1996
  59. Komel R
    Tehnologija rekombinantne DNK v medicinskih raziskavah in uporabi
    [Recombinant DNA technology in medical research and application]
    1996
  60. Štrukelj B
    Metodologija in tehnike rekombinantne DNK
    [Methodologies and techniques of recombinant DNA]
    1996
  61. de Joncheere K
    The role of the pharmacist in WHO/EURO pharmaceutical programme
    1996
  62. Steinbach D
    Pharmaceutical care: international aspects and policies of FIP
    1996
  63. Miharija-Gala T
    Farmacevtska oskrba in preskrba
    [Pharmaceutical care and supply]
    1996
  64. Jevtič V; Šuput D
    Klinična uporaba slikanja z magnetno resonanco
    [Clinical applications of magnetic resonance imaging]
    1990
  65. Šuput D; Zupan A; Likar B; Zidanšek A; Sepe A; Demšar F
    Diagnostika patologije mišic s slikanjem z magnetno resonanco
    [Diagnostics of muscle pathology by magnetic resonance imaging]
    1990
  66. Krbavčič A
    Magister farmacije, prof. dr. Dušan Karba, osemdesetletnik
    1995
  67. Špringer J
    Homo pharmaceuticalis: božanski človek v štirinajstih besedah
    1995
  68. Blažič L
    Homeopatska zdravila
    1995
  69. Krbavčič A
    Homeopatija
    1995
  70. Senčar-Božič P; Srčič S; Knez Ž
    Uporabnost superkritičnih fluidov v farmacevtski tehnologiji
    [Applicability of supercritical fluids in processing of pharmaceuticals]
    1995
  71. Mlekuž S
    Teoretične osnove in uporabnost fluorescenčne spektroskopije v farmaciji
    [Theoretical backgrounds and applicability of fluorescent spectroscopy in pharmacy]
    1995
  72. Rutar A; Kikelj D
    Kombinatorične kemijske knjižnice
    [Combinatorial chemical libraries]
    1995
  73. Zorec R
    Ob rob zakonodaji in delu z laboratorijskimi živalmi
    1995
  74. Špringer J
    Gornjeradgonsko okno, sestavljeno iz štirih šip spominov in hrepenenja
    1995
  75. Krbavčič A
    Simboli v lekarništvu in nova naslovnica Farmacevtskega vestnika
    1995
  76. Predin Š
    Ustanovitev lekarn v Murski Soboti in Ljutomeru
    [Foundation of pharmacies in Murska Sobota and Ljutomer]
    1995
  77. Klofutar C; Marinko R
    Elektrolitska prevodnost vodnih raztopin medu
    [Electrolytic conductivity of aqueous solutions of honey]
    1995
  78. Vrhnjak K; Urleb U
    Uporaba ciklodekstrinov v sintezi optično aktivnih snovi
    [Use of cyclodextrins in synthesis of optically active compounds]
    1995
  79. Stopar T
    Radioaktivni pripravki in validacija njihove priprave
    [Radiopharmaceuticals and validation of their preparation]
    1995
  80. Punčuh A; Morosini-Berus E; Kotar-Jordan B
    Solid-state interaction studies of glipizide with excipients using thermal analysis and thin layer chromatography (TLC)
    1995
  81. Gašperlin M; Šmid-Korbar J; Kristl J
    Viscoelastic and release behaviour of semisolid emulsions containing ibuprofen
    1995
  82. Sejfulah SM; Krsteska L
    The effects of different antioxidants on lidocain-adrenaline injections
    1995
  83. Vandelli MA; Panini R; Salvioli G; Bernabei MT; Cameroni R
    2-hydroxypropyl-beta-cyclodextrin in the protection of haemolysis induced by bile acid
    1995
  84. Grošelj J; Srčič S
    Fluid bed and vacuum drying of agglomerates
    1995
  85. Žmitek J; Verhnjak K; Urleb U; Bole B; Kerč J; Kotnik S; Grosman P
    S-(+)-ibuproxam and its beta-cyclodextrin complexes
    1995
  86. Krsteska L; Sejfulah SM
    Increasing solubility and masking unplesant taste of paracetamol in oral pharmaceutical formulation
    1995
  87. Resman A; Jelen-Žmitek A; Jereb M; Kotnik S; Kovačič M; Lazarevski K; Žmitek J
    Solubility dependence of selected active substances
    1995
  88. Mlekuž S; Kristl J; Šmid-Korbar J; Vrečer F; Rotar A
    Swelling behaviour of HPMC, HPC and HEC peroral matrix systems
    1995
  89. Humar V; Grošelj J; Kerč J
    Characterisation of different batches of magnesium stearate for evaluation its lubricating efficiency
    1995
  90. Kočevar-Nared J; Kristl J; Šmid-Korbar J
    Comparative rheological investigation of crude gastric mucin and natural gastric mucus
    1995
  91. Čufar A; Kristl J
    Evaluation of sunscreen preparations efficacy using an in vitro method
    1995
  92. Kramar A; Vrečer F; Kuhar V
    Study of Fe2+ release from multiparticulate hydrophilic matrix systems
    1995
  93. Hočevar M; Kofler B
    Influence of stearic acid on viscosity of emulsions
    1995
  94. Kerč J; Srčič S; Planinšek O; Kofler B
    Monotropic and enantiotropic polymorphic forms of felodipine and nimodipine
    1995
  95. Širca J; Srčič S; Kofler B
    Influence of disintegrants on the dissolution of ketoprofen from pelleas made by extrusion/spheronisation
    1995
  96. Zupančič-Božič D; Vrečer F; Kozjek F
    Optimization od diclofenac sodium dissolution from sustained release tablets using artificial neural network
    1995
  97. Planinšek O; Srčič S; Kerč J
    Some physicochemical properties of amlodipine and nicardipine
    1995
  98. Stublar-Dragoš M; Mrhar A; Kapš R
    Optimization of gentamicin dosing in intensive care patients using a computer-aided approach
    1995
  99. Primožič S; Avsec M
    Developing the tools for bioequivalence assessment
    1995
  100. Gabrijelčič V; Šentjurc M
    Liposome-skin interactions as studied by EPR methods on liotropic model systems
    1995

   38 138 238 338 438 538 638 738 838 938  


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko